PRT3789 is a First-in-Human SMARCA2-Selective Degrader that Induces Synthetic Lethality in SMARCA4-Mutated Cancers

已完结 20 由小小发布于 2026/7/6 16:34:07

DOI:10.1158/0008-5472.can-25-1141
作者：Michael Hulse, Min Wang, Chaoyi Xu, Jack Carter, Anjana Agarwal, Liang Lu, Philip Pitis, Neha Bhagwat, Joseph Rager, Justin Kurian, Corey Basch, Monisha Sivakumar, Jessica Burtell, Arpita Mondal, Alex
文献类型：期刊论文
补充材料：只需要正文

American Association for Cancer Research (AACR)

Abstract：SMARCA2 and SMARCA4 are the core catalytic subunits of the SWI/SNF chromatin remodeling complex. Approximately 10% of non-small cell lung cancer (NSCLC) patients harbor SMARCA4 mutations, re

应助信息

1小时前

肉肉

fe2bb521791611f1b8a734735aa3bc31.pdf 已采纳

1小时前

Book学术机器人

2026/7/6 16:34:07 未找到该文献，机器人已退出，请等待人工下载

2026/7/6 16:34:07 Book学术AI机器人收到请求，开始寻找文献

2026/7/6 16:34:07 已向机器人发送请求

1小时前

小小发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库Hydrogen-Bond-Networked Robust Binder Enabling Long-Cycling Sulfide-Based All-Solid-State Lithium Batteries.